2020

Conquering Neuromyelitis Optica Through Early, Accurate Diagnosis and Novel Therapeutics

Visit USCO

Text Registration

Conquering Neuromyelitis Optica Through Early, Accurate Diagnosis and Novel Therapeutics

Status

Published

on 15 Jan 2020

Year of Creation

2019

Med-IQ

Registration Number

TX0008839981

on 15 Jan 2020

The U.S. Copyright record (Registration Number: TX0008839981) dated 15 Jan 2020, pertains to an electronic file (eService) titled "Conquering Neuromyelitis Optica Through Early, Accurate Diagnosis and Novel Therapeutics " created in 2019. The copyright holder is Med-IQ, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Med-IQ.

Med-IQ

Application Details

Registration Number

TX0008839981

Registration Date

1/15/2020

Year of Creation

2019

Agency Marc Code

DLC-CO

Record Status

New

Corporate Author

Med-IQ

Physical Description

Electronic file (eService)

First Publication Nation

United States

Corporate Authors

Med-IQ

Notes

Rights Note: Susan Dembeck, Med-IQ, 5523 Research Park Dr, Ste 210, Baltimore, MD, 21228, United States, (443) 543-5114, sdembeck@med-iq.com

Statements

Application Title Statement: Conquering Neuromyelitis Optica Through Early, Accurate Diagnosis and Novel Therapeutics

Author Statement: Med-IQ employer for hire Domicile: United States Authorship: text

Notes

Rights Note: Susan Dembeck, Med-IQ, 5523 Research Park Dr, Ste 210, Baltimore, MD, 21228, United States, (443) 543-5114, sdembeck@med-iq.com

Statements

Application Title Statement: Conquering Neuromyelitis Optica Through Early, Accurate Diagnosis and Novel Therapeutics

Author Statement: Med-IQ employer for hire Domicile: United States Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.